Abraxis Bioscience, Inc. | air pollution violation | 2012 | CA-SCAQMD | $5,000 |
BRISTOL-MYERS SQUIBB COMPANY | environmental violation | 2000 | EPA | $5,000 |
E R SQUIBB & SONS LLC | air pollution violation | 2013 | NJ-ENV | $5,950 |
BRISTOL-MYERS SQUIBB CO | air pollution violation | 2001 | NJ-ENV | $6,000 |
Celgene Corporation | PCB violation | 2013 | EPA | $6,035 |
DuPont Pharmaceuticals Company | economic sanction violation | 2004 | OFAC | $6,600 |
E.R. Squibb & Sons LLC | PCB violation | 2009 | EPA | $8,125 |
E.R. SQUIBB & SONS | environmental violation | 2009 | NJ-ENV | $10,000 |
BRISTOL-MYERS SQUIBB | environmental violation | 2023 | MA-ENV | $11,615 |
BRISTOL MYERS SQUIBB CO | hazardous waste violation | 2005 | NJ-ENV | $12,000 |
Bristol-Myers Squibb Medical Imaging, Inc. | export control violation | 2004 | BIS | $16,200 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | air pollution violation | 2009 | EPA | $19,538 |
Bristol-Myers Squibb Company | environmental violation | 2011 | CT-ENV | $20,000 |
BRISTOL-MYERS SQUIBB CO | air pollution violation | 2003 | NJ-ENV | $28,000 |
Bristol Myers Squibb Manufacturing Company | hazardous waste violation | 2008 | EPA | $52,000 |
Bristol Myers Squibb Company | air pollution violation | 2008 | EPA | $66,770 |
American Pharmaceutical Partners, Inc. | wage and hour violation | 2004 | WHD | $160,203 |
American BioScience Inc. | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
Bristol-Myers Squibb | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
Bristol-Myers Squibb Company | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Bristol-Myers Squibb Company | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Bristol-Myers Squibb | air pollution violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
Bristol-Myers Squibb | air pollution violation | 2008 | EPA | $3,650,000 |
Bristol-Myers Squibb Co. | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Bristol-Myers Squibb Co. | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
Celgene Corp. | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
Celgene Corporation | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $34,000,000 |
Briston-Myers Squibb | benefit plan administrator violation | 2005 | private lawsuit-federal | $41,220,000 |
DuPont Pharmaceuticals Company | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $44,500,000 |
Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $65,000,000 |
Bristol-Myers Squibb | False Claims Act and related | 2021 | USAO | $75,000,000 |
Bristol Myers Squibb Co. | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
Bristol-Myers Squibb Co. | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $100,000,000 |
Bristol-Myers Squibb Company | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Bristol-Myers Squibb Company | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $220,000,000 |
Celgene Corp. | False Claims Act and related | 2017 | USAO | $280,000,000 |
Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
Bristol-Myers Squibb Company | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |